(SARS-COV-2) PCR Test Development (20 April RNS)26 May 2020 17:31
News very soon
David Budd, Chief Executive Officer of Genedrive plc, says: "We have extensive experience working with the Cytiva team on assay development and manufacturing for our Point of Care HCV, AIHL, and military programmes. We are pleased to now apply that partnership in a high throughput manufacturing process, which we believe places us amongst a small group of companies that have the capability to produce simple assay solutions at significant scale. We are working very aggressively and plan to have product available in the next five weeks."